Clinical Trials
MBQ Pharma announces the First-in-Human Dose of MBQ-167 for Advanced Breast Cancer in a Phase 1 Clinical Trial in Puerto Rico with the dual targeted Rac/Cdc42 inhibitor
- MBQ-167 is a first-in-class small molecule and dual targeted inhibitor of over-expression of two proteins (Rac and Cdc42)…
WORKING TOWARDS A CLINICAL TRIAL CULTURE IN PUERTO RICO
Working towards a clinical trial culture in Puerto Rico By: Natasha DeLeon-Rodriguez, Ph.D. Doctors and researchers work…
Cursos cortos de verano en el Departamento de Bioestadísticas, Universidad de Washington
The Summer Institutes consist of a series of short workshops conducted by experts in the subject fields and designed to…
Cursos cortos en bioestadísticas, epidemiología, genética y estudios clínicos
El Departamento de Bioestadísticas en la Universidad de Washington, Seattle, WA se complace en anunciar sus Institutos de…